EECP: Contraindications
EECP: Contraindications
- Cardiac catheterization within two weeks to minimize the likelihood of bleeding at the femoral puncture site.
- Arrhythmia, such as atrial fibrillation, atrial flutter, or ventricular tachycardia, might interfere with triggering the system.
- Uncontrolled congestive heart failure may result in left ventricular unloading insufficient to compensate for increased venous return during EECP.
- Aortic insufficiency where regurgitation would prevent diastolic augmentation.
- Limiting peripheral vascular disease and/or phlebitis because of increased risk of thromboembolus. Severe condition can compromise effective counterpulsation.
- Severe hypertension (less than180/110 mmhg) because EECP could produce diastolic blood pressure levels surpassing limits.
- Bleeding diathesis, warfarin therapy because cuff pressure could cause intramuscular bleeding.
- Pregnancy.
Precautions
Therapy should be terminated if any of the following events occur during the course of treatment:
- acute myocardial infarction;
- sustained arrhythmia;
- unstable anginal pattern that warrants additional therapy.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.